The fixed combination of the drugs saxagliptin and metformin (Komboglyze®) has been approved in Germany since November 2011 for the treatment of type 2 diabetes mellitus.
Read more
Medical News Today – Saxagliptin/Metformin Combo: Added Benefit Not Proven for TII